- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04785482
The PaTHS Descriptive Correlational Longitudinal Study (PaTHS)
July 21, 2022 updated by: Melissa Elliott, Children's Mercy Hospital Kansas City
Parents Post-traumatic Stress Before and After Their Infant's Second Palliative Heart Surgery: The PaTHS Descriptive Correlational Longitudinal Study
The primary objective of this study is to measure parent's post-traumatic stress before and after their infant's second palliative heart surgery for single ventricle congenital heart disease.
The investigators will use the posttraumatic stress disorder checklist for the DSM-V (PCL-5) to measure levels 2-4 weeks before and after the infant's second heart surgery.
The investigators aim to describe the levels at the two-time points, compare the scores, and identify demographic information that correlates with the scores.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospitals and Clinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Parents of infants with single ventricle congenital heart disease participating in the Cardiac High Acuity Monitoring Program (CHAMP)
Description
Inclusion Criteria:
- Parent who is 18 years or older of an infant with SVCHD
- Following with CHAMP through Children's Mercy Hospital. Any person personally identifying as a parent of the child, who lives in the same household as the infant, and who will provide primary care after discharge from the hospital is eligible to participate.
Exclusion Criteria:
- Parents of an SVCHD infant who is undergoing end-of-life care, determined by the primary care team.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
|---|
|
Parents of infants with single ventricle heart disease
All participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure the level of parental post-traumatic stress two to four weeks before their infant's second palliative heart surgery
Time Frame: on average at 4-6 months of age
|
Measure level using the posttraumatic stress disorder checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.
The scores range 0-80 with scores greater than or equal to 31 suggest provisional Posttraumatic stress disorder diagnosis.
|
on average at 4-6 months of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure the level of parental post-traumatic stress two to four weeks after discharge following their infant's second palliative heart surgery.
Time Frame: On average 5-6 months of age
|
Measure level using the posttraumatic stress disorder checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.
The scores range 0-80 with scores greater than or equal to 31 suggest provisional Posttraumatic stress disorder diagnosis.
|
On average 5-6 months of age
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Examine the relationship of parental post-traumatic stress level before and after their infant's second palliative heart surgery.
Time Frame: through study completion, an average of 1 year
|
Compare the two PCL-5 scores.
|
through study completion, an average of 1 year
|
|
Examine what demographic variables are the mediators and moderators of the correlations.
Time Frame: through study completion, an average of 1 year
|
Examine any correlation between selected demographics and PCL-5 scores.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Melissa Elliott, Advanced Practice Registered Nurse
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Actual)
June 9, 2022
Study Completion (Actual)
June 9, 2022
Study Registration Dates
First Submitted
March 3, 2021
First Submitted That Met QC Criteria
March 4, 2021
First Posted (Actual)
March 8, 2021
Study Record Updates
Last Update Posted (Actual)
July 22, 2022
Last Update Submitted That Met QC Criteria
July 21, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001652
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Single-ventricle
-
Timothy Icenogle, MDWithdrawnSingle-ventricle | Failing Fontan Physiology | Failing Fontan | Single-ventricle Fontan | Single-ventricle PhysiologyUnited States
-
University of MichiganTerminated
-
Hacettepe UniversityCompleted
-
Emory UniversityTerminatedAmbulatory Children With Single VentricleUnited States
-
Advocate Hospital SystemRecruiting
-
Barbara BurkhardtNot yet recruitingSingle-ventricleSwitzerland
-
Mezzion Pharma Co. LtdRecruitingSingle Ventricle Heart DiseaseUnited States, South Korea
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI)CompletedSingle Ventricle Heart DiseaseUnited States, Korea, Republic of, Canada
-
The University of Texas Health Science Center,...UnknownSingle Ventricle PhysiologyUnited States